NFXL1_HUMAN - dbPTM
NFXL1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID NFXL1_HUMAN
UniProt AC Q6ZNB6
Protein Name NF-X1-type zinc finger protein NFXL1
Gene Name NFXL1
Organism Homo sapiens (Human).
Sequence Length 911
Subcellular Localization Membrane
Single-pass membrane protein .
Protein Description
Protein Sequence MEASWRQVAGGRGRSRGRATAAPSGNGVHLRGAGGGREKGSVGAVPSGTSPGGVATTAAAGSRHSPAGSQALQTTAASELMSQKKFEEIKKANQAAARKLVEEQFSSSSEEGDEDFEGKQGKILANTFITYTTQTDGDTRELERTKQYVNEAFQAGAMTCLICIASVKRNQAVWSCSGCFCIFHMPCIQKWAKDSQFLVSSVTDDDFGKKDCPWPCPKCRFEYKRSETPSRYYCYCGKVEDPPLDPWLVPHSCGQVCEREFKPPCGHKCLLLCHPGPCPPCPKMVTTTCYCKKAKPIPRRCSAKEWSCQLPCGQKLLCGQHKCENPCHAGSCQPCPRVSRQKCVCGKKVAERSCASPLWHCDQVCGKTLPCGNHTCEQVCHVGACGECPRSGKRFCPCQKSKFSLPCTEDVPTCGDSCDKVLECGIHRCSQRCHRGPCETCRQEVEKHCRCGKHTKRMPCHKPYLCETKCVKMRDCQKHQCRRKCCPGNCPPCDQNCGRTLGCRNHKCPSVCHRGSCYPCPETVDVKCNCGNTKVTVPCGRERTTRPPKCKEQCSRPPTCHHTSQEKHRCHFGSCPPCHQPCQKVLEKCGHLCPAPCHDQALIKQTGRHQPTGPWEQPSEPAFIQTALPCPPCQVPIPMECLGKHEVSPLPCHAVGPYSCKRVCGRILDCQNHTCMKECHKVTKTDGCTGKNKAGPECLHCEEGCSKSRPLGCLHPCILRCHPGECPPCVQMLRIKCHCKITSLYVECRKITTADVNEKNLLSCCKNQCPKELPCGHRCKEMCHPGECPFNCNQKVKLRCPCKRIKKELQCNKVRENQVSIECDTTCKEMKRKASEIKEAEAKAALEEEKRRQQAELEAFENRLKGRRKKNRKRDEVAVELSLWQKHKYYLISVCGVVVVVFAWYITHDVN
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
4Phosphorylation----MEASWRQVAGG
----CCCCCHHHCCC
14.9724719451
18MethylationGRGRSRGRATAAPSG
CCCCCCCCCCCCCCC
27.8824384531
39UbiquitinationGAGGGREKGSVGAVP
CCCCCCCCCCEECCC
55.94-
41PhosphorylationGGGREKGSVGAVPSG
CCCCCCCCEECCCCC
28.5724732914
47PhosphorylationGSVGAVPSGTSPGGV
CCEECCCCCCCCCCC
48.3725159151
49PhosphorylationVGAVPSGTSPGGVAT
EECCCCCCCCCCCCC
35.7725159151
50PhosphorylationGAVPSGTSPGGVATT
ECCCCCCCCCCCCCC
25.6925159151
56PhosphorylationTSPGGVATTAAAGSR
CCCCCCCCCCCCCCC
17.9824732914
57O-linked_GlycosylationSPGGVATTAAAGSRH
CCCCCCCCCCCCCCC
12.4528657654
57PhosphorylationSPGGVATTAAAGSRH
CCCCCCCCCCCCCCC
12.4524732914
62PhosphorylationATTAAAGSRHSPAGS
CCCCCCCCCCCCCHH
23.3024732914
65PhosphorylationAAAGSRHSPAGSQAL
CCCCCCCCCCHHHHH
18.4830266825
69PhosphorylationSRHSPAGSQALQTTA
CCCCCCHHHHHHHHH
17.8730266825
74PhosphorylationAGSQALQTTAASELM
CHHHHHHHHHHHHHH
21.1823663014
75PhosphorylationGSQALQTTAASELMS
HHHHHHHHHHHHHHC
13.7823663014
78PhosphorylationALQTTAASELMSQKK
HHHHHHHHHHHCHHH
28.8824732914
82PhosphorylationTAASELMSQKKFEEI
HHHHHHHCHHHHHHH
52.0124732914
84AcetylationASELMSQKKFEEIKK
HHHHHCHHHHHHHHH
52.7226051181
84UbiquitinationASELMSQKKFEEIKK
HHHHHCHHHHHHHHH
52.72-
90UbiquitinationQKKFEEIKKANQAAA
HHHHHHHHHHHHHHH
49.46-
106PhosphorylationKLVEEQFSSSSEEGD
HHHHHHHHCCCCCCC
29.0728102081
107PhosphorylationLVEEQFSSSSEEGDE
HHHHHHHCCCCCCCC
38.8922617229
108PhosphorylationVEEQFSSSSEEGDED
HHHHHHCCCCCCCCC
40.3422617229
109PhosphorylationEEQFSSSSEEGDEDF
HHHHHCCCCCCCCCC
41.4328102081
122UbiquitinationDFEGKQGKILANTFI
CCCCCCCEEEEEEEE
31.86-
193UbiquitinationPCIQKWAKDSQFLVS
HHHHHHHCCCCEEEE
57.72-
203PhosphorylationQFLVSSVTDDDFGKK
CEEEEECCCCCCCCC
35.34-
209AcetylationVTDDDFGKKDCPWPC
CCCCCCCCCCCCCCC
45.4926051181
209UbiquitinationVTDDDFGKKDCPWPC
CCCCCCCCCCCCCCC
45.49-
209 (in isoform 2)Ubiquitination-45.49-
210UbiquitinationTDDDFGKKDCPWPCP
CCCCCCCCCCCCCCC
66.01-
265S-palmitoylationEREFKPPCGHKCLLL
CCCCCCCCCCEEEEE
13.9621044946
292UbiquitinationVTTTCYCKKAKPIPR
EEEEEEECCCCCCCC
29.32-
293UbiquitinationTTTCYCKKAKPIPRR
EEEEEECCCCCCCCC
59.07-
315UbiquitinationCQLPCGQKLLCGQHK
CCCCCCCEEECCCCC
28.80-
322AcetylationKLLCGQHKCENPCHA
EEECCCCCCCCCCCC
35.0426051181
322UbiquitinationKLLCGQHKCENPCHA
EEECCCCCCCCCCCC
35.04-
331PhosphorylationENPCHAGSCQPCPRV
CCCCCCCCCCCCCCC
15.4623927012
339PhosphorylationCQPCPRVSRQKCVCG
CCCCCCCCCCCCCCC
30.2129888752
353PhosphorylationGKKVAERSCASPLWH
CHHHHHHHCCCCCCC
12.9229449344
354S-palmitoylationKKVAERSCASPLWHC
HHHHHHHCCCCCCCH
5.6421044946
356PhosphorylationVAERSCASPLWHCDQ
HHHHHCCCCCCCHHH
25.5028985074
361S-palmitoylationCASPLWHCDQVCGKT
CCCCCCCHHHHCCCC
2.3721044946
365S-palmitoylationLWHCDQVCGKTLPCG
CCCHHHHCCCCCCCC
3.7221044946
371S-palmitoylationVCGKTLPCGNHTCEQ
HCCCCCCCCCCCCCC
10.8221044946
376S-palmitoylationLPCGNHTCEQVCHVG
CCCCCCCCCCEEECC
2.4021044946
380S-palmitoylationNHTCEQVCHVGACGE
CCCCCCEEECCCCCC
1.8421044946
385S-palmitoylationQVCHVGACGECPRSG
CEEECCCCCCCCCCC
3.7621044946
388S-palmitoylationHVGACGECPRSGKRF
ECCCCCCCCCCCCCC
1.7421044946
396S-palmitoylationPRSGKRFCPCQKSKF
CCCCCCCCCCCCCCC
3.7021044946
398S-palmitoylationSGKRFCPCQKSKFSL
CCCCCCCCCCCCCCC
9.2921044946
400UbiquitinationKRFCPCQKSKFSLPC
CCCCCCCCCCCCCCC
63.43-
402AcetylationFCPCQKSKFSLPCTE
CCCCCCCCCCCCCCC
46.1126051181
402UbiquitinationFCPCQKSKFSLPCTE
CCCCCCCCCCCCCCC
46.11-
404PhosphorylationPCQKSKFSLPCTEDV
CCCCCCCCCCCCCCC
34.8328555341
420UbiquitinationTCGDSCDKVLECGIH
CCCHHHHHHHHHHHH
53.71-
462UbiquitinationTKRMPCHKPYLCETK
CCCCCCCCCEEEECC
41.91-
464PhosphorylationRMPCHKPYLCETKCV
CCCCCCCEEEECCCE
28.87-
468PhosphorylationHKPYLCETKCVKMRD
CCCEEEECCCEEHHH
28.8421949786
469UbiquitinationKPYLCETKCVKMRDC
CCEEEECCCEEHHHH
18.10-
472UbiquitinationLCETKCVKMRDCQKH
EEECCCEEHHHHCHH
37.37-
484UbiquitinationQKHQCRRKCCPGNCP
CHHHHHCCCCCCCCC
22.34-
484 (in isoform 2)Ubiquitination-22.34-
507UbiquitinationTLGCRNHKCPSVCHR
CCCCCCCCCCCCCCC
51.93-
516PhosphorylationPSVCHRGSCYPCPET
CCCCCCCCCCCCCCC
15.5028152594
518PhosphorylationVCHRGSCYPCPETVD
CCCCCCCCCCCCCEE
15.0128152594
527UbiquitinationCPETVDVKCNCGNTK
CCCCEEEEECCCCCE
18.44-
528S-palmitoylationPETVDVKCNCGNTKV
CCCEEEEECCCCCEE
5.2421044946
530S-palmitoylationTVDVKCNCGNTKVTV
CEEEEECCCCCEEEE
6.6121044946
534UbiquitinationKCNCGNTKVTVPCGR
EECCCCCEEEEECCC
39.65-
563PhosphorylationRPPTCHHTSQEKHRC
CCCCCCCCCCCCCCC
14.4023879269
564PhosphorylationPPTCHHTSQEKHRCH
CCCCCCCCCCCCCCC
31.8023879269
567UbiquitinationCHHTSQEKHRCHFGS
CCCCCCCCCCCCCCC
28.81-
584UbiquitinationPCHQPCQKVLEKCGH
CCCHHHHHHHHHHCC
56.35-
588UbiquitinationPCQKVLEKCGHLCPA
HHHHHHHHHCCCCCC
41.16-
589S-palmitoylationCQKVLEKCGHLCPAP
HHHHHHHHCCCCCCC
2.7921044946
593S-palmitoylationLEKCGHLCPAPCHDQ
HHHHCCCCCCCCCCH
1.9321044946
597S-palmitoylationGHLCPAPCHDQALIK
CCCCCCCCCCHHHHH
6.3221044946
604UbiquitinationCHDQALIKQTGRHQP
CCCHHHHHHCCCCCC
42.53-
644UbiquitinationIPMECLGKHEVSPLP
CCHHHCCCCCCCCCC
24.52-
648PhosphorylationCLGKHEVSPLPCHAV
HCCCCCCCCCCCCCC
20.1025159151
659PhosphorylationCHAVGPYSCKRVCGR
CCCCCCCCHHHHHHH
19.1225159151
661UbiquitinationAVGPYSCKRVCGRIL
CCCCCCHHHHHHHHH
41.76-
677UbiquitinationCQNHTCMKECHKVTK
CCCCCCHHHHCEECC
60.37-
681UbiquitinationTCMKECHKVTKTDGC
CCHHHHCEECCCCCC
64.36-
684UbiquitinationKECHKVTKTDGCTGK
HHHCEECCCCCCCCC
47.83-
691UbiquitinationKTDGCTGKNKAGPEC
CCCCCCCCCCCCCCC
36.80-
693UbiquitinationDGCTGKNKAGPECLH
CCCCCCCCCCCCCCC
59.20-
698S-palmitoylationKNKAGPECLHCEEGC
CCCCCCCCCCCCCCC
3.3721044946
701S-palmitoylationAGPECLHCEEGCSKS
CCCCCCCCCCCCCCC
3.0821044946
705S-palmitoylationCLHCEEGCSKSRPLG
CCCCCCCCCCCCCCC
5.3921044946
708PhosphorylationCEEGCSKSRPLGCLH
CCCCCCCCCCCCCCC
23.8823898821
740UbiquitinationLRIKCHCKITSLYVE
HEEEEEEEEEEEEEE
25.92-
742PhosphorylationIKCHCKITSLYVECR
EEEEEEEEEEEEEEE
9.7323312004
743PhosphorylationKCHCKITSLYVECRK
EEEEEEEEEEEEEEE
22.6023312004
745PhosphorylationHCKITSLYVECRKIT
EEEEEEEEEEEEECC
8.25-
750UbiquitinationSLYVECRKITTADVN
EEEEEEEECCCCCCC
56.94-
759UbiquitinationTTADVNEKNLLSCCK
CCCCCCHHHHHHHHH
47.92-
766UbiquitinationKNLLSCCKNQCPKEL
HHHHHHHHCCCCCCC
55.14-
771UbiquitinationCCKNQCPKELPCGHR
HHHCCCCCCCCCCCC
78.49-
780UbiquitinationLPCGHRCKEMCHPGE
CCCCCCHHHCCCCCC
48.73-
795UbiquitinationCPFNCNQKVKLRCPC
CCCCCCCCCEEECCC
27.61-
807UbiquitinationCPCKRIKKELQCNKV
CCCHHHHHHHCCCCC
62.37-
813UbiquitinationKKELQCNKVRENQVS
HHHHCCCCCCCCCCC
50.74-
820PhosphorylationKVRENQVSIECDTTC
CCCCCCCCEEECCHH
11.6928857561
825PhosphorylationQVSIECDTTCKEMKR
CCCEEECCHHHHHHH
45.8325627689
835PhosphorylationKEMKRKASEIKEAEA
HHHHHHHHHHHHHHH
42.7823927012
838UbiquitinationKRKASEIKEAEAKAA
HHHHHHHHHHHHHHH
46.98-
843UbiquitinationEIKEAEAKAALEEEK
HHHHHHHHHHHHHHH
26.20-
850UbiquitinationKAALEEEKRRQQAEL
HHHHHHHHHHHHHHH
57.04-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of NFXL1_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of NFXL1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of NFXL1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of NFXL1_HUMAN !!

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of NFXL1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50; SER-65; SER-106;SER-107; SER-108 AND SER-109, AND MASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106; SER-107; SER-108AND SER-109, AND MASS SPECTROMETRY.

TOP